Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy

The HIV infection is responsible for the most devastating global pandemic of the last century. More than 39 million people have died of HIV/AIDS since 1981. The development of the antiretroviral (ARV) treatment begins with the discovery of zidovudine a nucleoside reverse transcriptase inhibitor. Thi...

Full description

Bibliographic Details
Published in:	Frontiers in Microbiology
Main Authors:	Simona A. Iacob, Diana G. Iacob
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-11-01
Subjects:	ibalizumab antiretrovirals entry inhibitors monoclonal antibody HIV infection therapy
Online Access:	http://journal.frontiersin.org/article/10.3389/fmicb.2017.02323/full

Similar Items

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41
by: Hongxia Yan, et al.
Published: (2022-05-01)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
by: Jing Pu, et al.
Published: (2019-08-01)

Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment—Clinical Points of View and Practical Considerations
by: Simona A. Iacob, et al.
Published: (2017-11-01)

MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
by: Grupping Katrijn, et al.
Published: (2012-05-01)

Recent Insights into the HIV/AIDS Pandemic
by: Juan C. Becerra, et al.
Published: (2016-09-01)

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
by: Hager Mohamed, et al.
Published: (2022-01-01)

Epitope–Paratope Interaction of a Neutralizing Human Anti-Hepatitis B Virus PreS1 Antibody That Recognizes the Receptor-Binding Motif
by: Jisu Hong, et al.
Published: (2021-07-01)

HIV-1 Diversity in the Envelope Glycoproteins: Implications for Viral Entry Inhibition
by: Sabrina E. M. Almeida, et al.
Published: (2013-02-01)

Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
by: Magdalena Schwarzmüller, et al.
Published: (2024-09-01)

Targeting the epidermal growth factor receptor (EGFR) - a new therapeutic option in oncology?
by: C Mamot
Published: (2006-01-01)

A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway
by: Shufeng Liu, et al.
Published: (2015-11-01)

Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence
by: Francois Rosset, et al.
Published: (2025-09-01)

Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor
by: Chaozai Zhang, et al.
Published: (2018-11-01)

HIV-1 Entry and Prospects for Protecting against Infection
by: Jean-François Bruxelle, et al.
Published: (2021-01-01)

Conformational activation and disulfide exchange in HIV-1 Env induce cell-free lytic/fusogenic transformation and enhance infection
by: Charles G. Ang, et al.
Published: (2025-03-01)

HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
by: Qianqian Qi, et al.
Published: (2017-01-01)

Small Molecule HIV-1 Attachment Inhibitors: Discovery, Mode of Action and Structural Basis of Inhibition
by: Yen-Ting Lai
Published: (2021-05-01)

Quaternary Interaction of the HIV-1 Envelope Trimer with CD4 and Neutralizing Antibodies
by: Qingbo Liu, et al.
Published: (2021-07-01)

FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques
by: Joanna Zikos, et al.
Published: (2024-12-01)

Passive and active antibody studies in primates to inform HIV vaccines
by: Ann J. Hessell, et al.
Published: (2018-02-01)

Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket
by: Asim K. Debnath, et al.
Published: (2013-01-01)

Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH)
by: Anna Gidari, et al.
Published: (2023-12-01)

HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium
by: Georgette D. Kanmogne
Published: (2024-04-01)

Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients
by: Matthew Weichseldorfer, et al.
Published: (2021-10-01)

Antiretroviral therapy effect on specific antibodies spectrum changes to HIV-1 individual antigenes from persons infected with different virus subtypes
by: L. N. Lukhverchik, et al.
Published: (2019-08-01)

Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FIT45
by: Alexander Falkenhagen, et al.
Published: (2017-06-01)

HIV-1 Entry and Membrane Fusion Inhibitors
by: Tianshu Xiao, et al.
Published: (2021-04-01)

Characterizing the Anti-HIV Activity of Papuamide A
by: Louis R. Barrows, et al.
Published: (2008-10-01)

Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV
by: Amanda Binkley, et al.
Published: (2024-10-01)

Gene Therapy Targeting HIV Entry
by: Chuka Didigu, et al.
Published: (2014-03-01)

Bioinformatics study of selective inhibitor from <i>Garcinia mangostana</i> L. tackle HIV‑1 infection
by: V. D. Kharisma, et al.
Published: (2024-01-01)

A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
by: Yan Lv, et al.
Published: (2023-11-01)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
by: Nicholas Gravbrot, et al.
Published: (2019-10-01)

Use of rosuvastatin to treat protease inhibitor-associated hypercholesterolaemia in a HIV-infected patient at high risk of cardiovascular diseases
by: Leonardo Calza
Published: (2010-09-01)

Progressive HIV infection in the presence of a raised CD4+ count: HIV/HTLV-1 co-infection
by: Ahmad Farid Haeri Mazanderani, et al.
Published: (2013-06-01)

Trends in management and outcomes of pregnant women living with HIV between 2008–2013 and 2014–2019: A retrospective cohort study
by: Olivia Brandon, et al.
Published: (2022-10-01)

Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study
by: Subhra Mandal, et al.
Published: (2022-06-01)

The Antisense Protein ASP of HIV-1 Enhances Viral Entry in CD4+ T Cells
by: Myriam Abla Houmey, et al.
Published: (2025-09-01)

Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa
by: Leigh F. Johnson, et al.
Published: (2017-07-01)

The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage
by: Jingyou Yu, et al.
Published: (2018-08-01)